Abstract
In recent years, accumulating articles have revealed that long non-coding RNAs (lncRNAs) play crucial roles in ischemic stroke (IS). A previous study found that lncRNA zinc finger antisense 1 (ZFAS1) was down-regulated in IS patients compared with healthy controls. However, the precise function of ZFAS1 in IS and its associated mechanism remain unclear. Cell viability was assessed by cell counting kit-8 (CCK8) assay. Cell apoptosis was analyzed by flow cytometry. Western blot assay and quantitative real-time polymerase chain reaction (qRT-PCR) were conducted to measure protein and RNA expression. The interaction between microRNA-186-5p (miR-186-5p) and ZFAS1 or MCL1 apoptosis regulator, BCL2 family member (MCL1) was confirmed by dual-luciferase reporter assay, RNA-pull down assay and RNA immunoprecipitation (RIP) assay. IS cell model was established through exposing N2a cells to oxygen and glucose deprivation (OGD). OGD exposure restrained the viability and induced the apoptosis of N2a cells. OGD exposure down-regulated the expression of ZFAS1 and up-regulated the level of miR-186-5p in a time-dependent manner. ZFAS1 overexpression alleviated OGD-mediated injury in IS cell model. MiR-186-5p was identified as a direct target of ZFAS1, and OGD-induced injury in IS cell model was attenuated by the silence of miR-186-5p. MiR-186-5p interacted with the 3′ untranslated region (3′UTR) of MCL1 messenger RNA (mRNA). ZFAS1 positively regulated MCL1 mRNA expression by sequestering miR-186-5p in N2a cells. ZFAS1 overexpression-mediated protective effects in IS cell model were partly overturned by the overexpression of miR-186-5p. MCL1 silencing partly counteracted the protective effects mediated by miR-186-5p silencing in IS cell model. In conclusion, ZFAS1 overexpression exerted a protective role in IS cell model to attenuate OGD-induced injury through targeting miR-186-5p/MCL1 axis. ZFAS1/miR-186-5p/MCL1 signaling might be a novel diagnostic marker and promising treatment target for IS patients.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this article.
Abbreviations
- lncRNA:
-
Long non-coding RNA
- miRNA:
-
MicroRNA
- ZFAS1:
-
Zinc finger antisense 1
- IS:
-
Ischemic stroke
- MCL1:
-
MCL1 apoptosis regulator, BCL2 family member
- OGD:
-
Oxygen and glucose deprivation
References
Allen CL, Bayraktutan U (2009) Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 4:461–470
Bao MH, Szeto V, Yang BB, Zhu SZ, Sun HS, Feng ZP (2018) Long non-coding RNAs in ischemic stroke. Cell Death Dis 9:281
Barry G (2014) Integrating the roles of long and small non-coding RNA in brain function and disease. Mol Psychiatry 19:410–416
Benjamin EJ, Virani SS, Callaway CW et al (2018) Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 137:e67–e492
Cai J, Wu J, Zhang H et al (2013) miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res 73:756–766
Chen L, Zhou Y, Li H (2018) LncRNA, miRNA and lncRNA-miRNA interaction in viral infection. Virus Res 257:25–32
Cheng X, Kan P, Ma Z et al (2018) Exploring the potential value of miR-148b-3p, miR-151b and miR-27b-3p as biomarkers in acute ischemic stroke. Biosci Rep 38:25
Clark BS, Blackshaw S (2014) Long non-coding RNA-dependent transcriptional regulation in neuronal development and disease. Front Genet 5:164
Diaz NF, Cruz-Resendiz MS, Flores-Herrera H, Garcia-Lopez G, Molina-Hernandez A (2014) MicroRNAs in central nervous system development. Rev Neurosci 25:675–686
Feng LL, Shen FR, Zhou JH, Chen YG (2019) Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity. Gene 696:105–112
Han CG, Huang Y, Qin L (2019) Long non-coding RNA ZFAS1 as a novel potential biomarker for predicting the prognosis of thyroid cancer. Med Sci Monit 25:2984–2992
Hankey GJ (2003) Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 16:14–19
Hassan A, Markus HS (2000) Genetics and ischaemic stroke. Brain 123:1784–1812
Huang Y (2018) The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med 22:5768–5775
Huang Y, Luo H, Li F et al (2018) LINC00152 down-regulated miR-193a-3p to enhance MCL1 expression and promote gastric cancer cells proliferation. Biosci Rep 38:40
Islam F, Gopalan V, Vider J et al (2017) MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor. Exp Cell Res 357:260–270
Liu XH, Sun M, Nie FQ et al (2014) Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer 13:92
Liu B, Cao W, Xue J (2019) LncRNA ANRIL protects against oxygen and glucose deprivation (OGD)-induced injury in PC-12 cells: potential role in ischaemic stroke. Artif Cells Nanomed Biotechnol 47:1384–1395
Mojsa B, Lassot I, Desagher S (2014) Mcl-1 ubiquitination: unique regulation of an essential survival protein. Cells 3:418–437
Munoz JP, Sanchez JR, Maccioni RB (2003) Regulation of p27 in the process of neuroblastoma N2A differentiation. J Cell Biochem 89:539–549
Nie F, Yu X, Huang M et al (2017) Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression. Oncotarget 8:38227–38238
Paraskevopoulou MD, Hatzigeorgiou AG (2016) Analyzing MiRNA-LncRNA interactions. Methods Mol Biol 1402:271–286
Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W (2015) ceRNA in cancer: possible functions and clinical implications. J Med Genet 52:710–718
Quinn JJ, Chang HY (2016) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17:47–62
Shi X, Sun M, Liu H, Yao Y, Song Y (2013) Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 339:159–166
Siddeek B, Inoubli L, Lakhdari N et al (2014) MicroRNAs as potential biomarkers in diseases and toxicology. Mutat Res 764:46–57
Tao F, Tian X, Lu M, Zhang Z (2018) A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c. J Genet Genom 45:137–145
Wang R, Bao H, Zhang S, Li R, Chen L, Zhu Y (2018a) miR-186-5p promotes apoptosis by targeting IGF-1 in SH-SY5Y OGD/R Model. Int J Biol Sci 14:1791–1799
Wang JS, Liu QH, Cheng XH, Zhang WY, Jin YC (2018b) The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329. Biomed Pharmacother 103:174–181
Wang J, Ruan J, Zhu M et al (2019) Predictive value of long noncoding RNA ZFAS1 in patients with ischemic stroke. Clin Exp Hypert 41:615–621
Wu S, Liu F, Xie L et al (2015) miR-125b suppresses proliferation and invasion by targeting MCL1 in gastric cancer. Biomed Res Int 2015:
Xu W, He L, Li Y, Tan Y, Zhang F, Xu H (2018) Silencing of lncRNA ZFAS1 inhibits malignancies by blocking Wnt/beta-catenin signaling in gastric cancer cells. Biosci Biotechnol Biochem 82:456–465
Yin S, Du W, Wang F et al (2018) MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway. Cancer Biol Ther 19:260–270
Zhao M, Wang J, Xi X, Tan N, Zhang L (2018) SNHG12 promotes angiogenesis following ischemic stroke via regulating miR-150/VEGF pathway. Neuroscience 390:231–240
Zheng T, Shi Y, Zhang J et al (2019) MiR-130a exerts neuroprotective effects against ischemic stroke through PTEN/PI3K/AKT pathway. Biomed Pharmacoth 117:
Zhou J, Chen L, Chen B et al (2018a) Increased serum exosomal miR-134 expression in the acute ischemic stroke patients. BMC Neurol 18:198
Zhou B, Li L, Li Y, Su H, Zeng C (2018b) Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis. Biomed Pharmacother 106:850–857
Zhu M, Li N, Luo P et al (2018) Peripheral blood leukocyte expression of lncRNA MIAT and its diagnostic and prognostic value in ischemic stroke. J Stroke Cerebrovascul Dis 27:326–337
Funding
This work was funded by Yancheng Development Project of Medical Science and Technology in 2020 (YK2020061)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no financial conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
10616_2021_481_MOESM1_ESM.tif
Supplementary file1 ZFAS1 overexpression rescues the expression of cyclin D1 in OGD-induced N2a cells. (A) The protein expression of cyclin D1 was determined in N2a cells in the following four groups by Western blot assay: control, OGD, OGD + vector and OGD + ZFAS1. (B) The level of cyclin D1 was measured in N2a cells in the following five groups by Western blot assay: control, OGD, OGD + vector + miR-NC, OGD + ZFAS1 + miR-NC and OGD + ZFAS1 + miR-186-5p. *P < 0.05, **P < 0.01. (TIFF 452 kb)
10616_2021_481_MOESM2_ESM.tif
Supplementary file2 The silence of MCL1 counteracts miR-186-5p knockdown-induced effects in N2a cells upon OGD stimulation better than the silence of IGF-1. (A and B) The mRNA and protein expression of IGF-1 was determined in N2a cells transfected with anti-NC + si-NC, anti-miR-186-5p + si-NC and anti-miR-186-5p + si-IGF-1. (C-G) N2a cells were divided into six groups: control group, OGD group, OGD + anti-NC + si-NC group, OGD + anti-miR-186-5p + si-NC group, OGD + anti-miR-186-5p + si-MCL1 group and OGD + anti-miR-186-5p + si-IGF-1 group. (C) CCK8 assay was applied to analyze cell viability. (D) Flow cytometry was employed to assess cell apoptosis rate. (E and F) Western blot assay was conducted to determine the expression of Bax, Bcl-2 and cleaved caspase-3 in N2a cells. (G) The level of cyclin D1 was determined in N2a cells by Western blot assay. *P < 0.05, **P < 0.01. (TIFF 1159 kb)
Rights and permissions
About this article
Cite this article
Shen, B., Wang, L., Xu, Y. et al. Long non-coding RNA ZFAS1 exerts a protective role to alleviate oxygen and glucose deprivation-mediated injury in ischemic stroke cell model through targeting miR-186-5p/MCL1 axis. Cytotechnology 73, 605–617 (2021). https://doi.org/10.1007/s10616-021-00481-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-021-00481-4